Back
NeuroMetrix 10K Form
Sell
29
NURO
NeuroMetrix
Last Price:
$3.82
Seasonality Move:
-6.74%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NURO News And Ratings
See the #1 stock for the next 7 days that we like better than NURO
NURO Financial Statistics
Sales & Book Value
| Annual Sales: | $5.9M |
|---|---|
| Cash Flow: | $-1.8M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $7.86 |
| Price / Book: | 0.5 |
Profitability
| EPS (TTM): | -4.24170 |
|---|---|
| Net Income (TTM): | $-7.7M |
| Gross Margin: | $3.9M |
| Return on Equity: | -41.7% |
| Return on Assets: | -38.57% |
NeuroMetrix Earnings Forecast
Key NeuroMetrix Financial Ratios
-
The Gross Profit Margin over the past 23 years for NURO is 66.89%.
-
The Selling, General & Administrative Expenses for NURO have been equal to 141.00% of Gross Profit Margin.
-
The Research & Development expenses have been 47.07% of Revenue.
-
The Interest Expense is 0.00% of Operating Income.
-
The Net Earning history of NURO is -110.64% of Total Revenues.
-
Per Share Earnings over the last 23 years have been positive in 13 years.
NeuroMetrix Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | NURO |
| CUSIP: | 641255 |
| Website: | neurometrix.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 13.88 |
| Quick Ratio: | 12.38 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NURO Technical Analysis vs Fundamental Analysis
Sell
29
NeuroMetrix (NURO)
is a Sell
Is NeuroMetrix a Buy or a Sell?
-
NeuroMetrix stock is rated a SellThe current NeuroMetrix [NURO] share price is $3.90. The Score for NURO is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.